Last Close
75.02 $
Jul 6, 26
Market Cap
3.5 B $
Q1 2026 (TTM)
52-Week Range
%-0.1
%54.0
-0.48
-0.51
%-13.9
-%40.1
1M
+5.2%
3M
+28.3%
6M
-8.6%
YTD
-6.4%
1Y
-2.4%
3Y
-10.6%
Returns are computed from split-adjusted closes; dividends are not included.
Stock and gold/silver returns are in USD (metals converted into the stock's currency). The S&P 500 index is measured in its own currency.
HAE last closed at 75.02 $ (Jul 6, 26). Price data is refreshed after every trading day.
Haemonetics Corporation trades at a trailing-twelve-month P/E of 35.64. See the comparison tables on the Peers tab for the industry context.
Haemonetics Corporation (HAE) has a market capitalization of approximately 3.5 B $ as of the latest reported period.
Key peers of Haemonetics Corporation include Cochlear Ltd, 4DMEDICAL Ltd, Koninklijke Philips NV, Siemens Healthineers AG, Smith & Nephew PLC. A detailed metric comparison is available on the Peers tab.
Data on this page refreshes once per day. Price data as of Jul 6, 26. This content is for informational purposes only and is not investment advice.